Preliminary but encouraging findings from a Phase 0 human clinical trial of a melanoma drug have been reported. Scientists found an approved drug used to treat Lou Gehrig's disease (ALS), slows the growth of melanoma, the most aggressive form of malignant skin cancer.
Post new comment